For Immediate Release
May 3, 2022
Phnom Penh, Cambodia
Today, the United States, in partnership with COVAX, UNICEF, and WHO donated two million Pfizer vaccine doses to the Royal Kingdom of Cambodia. These safe and effective vaccines will protect the Cambodian people and help prevent dangerous new variants from spreading.
“The United States considers achieving health security a top priority and we will continue to work with COVAX partners to ensure people around the world have access to vaccines,” said W. Patrick Murphy, U.S. Ambassador to the Royal Kingdom of Cambodia. “With this contribution, the United States reaffirms its longstanding commitment to the health and well-being of the people of Cambodia.”
In Cambodia, the United States has now provided a total of more than three million vaccine doses, $16 million in supplemental assistance through the United States Agency for International Development, and critical technical assistance through U.S. public health agencies throughout the pandemic, supporting surveillance, contract tracing, public awareness capacity, and research to stem the spread of COVID-19.
U.S. efforts have reached more than ten million Cambodians with risk communication materials via television, social media, radio, SMS messaging, and billboards. The support has improved laboratory capacity, strengthened healthcare workers’ skills, and helped to mitigate the economic impact of the pandemic.
The United States is committed to leading the global COVID-19 response which makes us all—Americans and Cambodians alike—safer and healthier. We are proud to work with Cambodia to end the COVID-19 pandemic.